Voice-Activated Technology for Frailty
(EngAGE Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Enhanced Engagement, EngAGE, Enhanced Engagement, Motivational Enhancement Therapy, Standard Engagement for frailty?
The research suggests that engaging older adults living with frailty and their caregivers in decision-making and care can be beneficial, as it considers their specific needs and empowers them. Additionally, using technology to monitor frailty remotely has shown positive user experiences and acceptance, indicating that similar engagement-focused treatments could be effective.12345
Is voice-activated technology for frailty safe for humans?
How does the Voice-Activated Technology for Frailty treatment differ from other treatments for frailty?
Voice-Activated Technology for Frailty is unique because it uses voice-activated systems to help manage frailty, which is different from traditional methods like exercise and nutrition programs. This approach leverages technology to provide a potentially low-cost and proactive way to monitor and manage frailty, although the evidence for its effectiveness is still developing.6791011
Research Team
Megan Huisingh-Scheetz, MD
Principal Investigator
University of Chicago
Eligibility Criteria
This trial is for African American individuals aged 65 or older with at least two chronic conditions and moderate mobility issues. They must need some assistance to leave home, be able to read on a tablet screen, hear spoken voice from a distance, and have no severe cognitive impairments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Run-In Period
Two-week period to troubleshoot the EngAGE app and acclimate participants to the study intervention
Treatment
Participants receive either the EngAGE intervention or usual care with physical exercise handouts
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Enhanced Engagement
- Standard Engagement
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
Rush University
Collaborator
National Opinion Research Center
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator